Cadila Healthcare Ltd's API manufacturing facility located at Dabhasa, Gujarat has received an Establishment Inspection Report (EIR). The USFDA had conducted an inspection at the facility from 7th to 11th October 2019. The EIR report stated that the classification of the facility is 'No Action Indicated (NAI)'.
Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.256.65 as compared to the previous close of Rs. 263.35. The total number of shares traded during the day was 27733 in over 517 trades.
The stock hit an intraday high of Rs. 264 and intraday low of 256.65. The net turnover during the day was Rs. 7223917.